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Prostaglandin H synthase (PGHS) as apo-PGHS, holo-PGHS, and holo-PGHS, inactivated in the course of catalysis was studied using chemical 
modification with dietbyl pyrocarbonate (DEPC). The exhausted reaction with DEPC corresponded to the modification of 7 histidine residues in 
apo-PGHS and 4 in holo-PGHS. All 18 histidine residues became accessible for modification with DEPC in the enzyme, inactivated in the course 
of catalysis. The velocities of tryptic cleavage of all the three forms into two fragments were fairly different but independent of modification. Based 
on the results we hypothesize fast and dramatic changes in the protein structure in the course of the substrate conversion. 
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1. INTRODUCTION 
Prostaglandin H synthase (PGHS) (EC 1.14.99.1) is 
the first and rate-limiting enzyme in the pathway in 
which polyunsaturated fatty acids (PUFA) are con- 
verted into prostanoids [l-3]. The enzyme displays cy- 
clooxygenase and peroxidase activities and requires 
heme [l-3]. 
The requirements of the enzyme active centre for the 
PUFA nature are very strict [3-51. In addition, great 
demands are known for the structural correlation be- 
tween enzyme and cofactor [6-121. 
Several ines of evidence suggest an important role of 
histidine residues in the catalysis by PGHS [6-81. We 
pointed out in preliminary studies [6,7] that their chem- 
ical modification with DEPC is accompanied by inacti- 
vation of the enzyme. The loss of enzyme activity was 
also shown to result from site-directed replacement of 
histidine residues with alanine or glutamine [7]. The 
authors [7j assumed His-309 as the axial ligand for heme 
binding (numeration of amino acid residues here and 
further is given according to ref. [13]). An alternative 
version based on the data of the chemical modification 
and the properties of mutant PGHS implies a promi- 
nent role in heme binding of Tyr-385 [9,10]. 
In a previous report [l l] we demonstrated that the 
substitution of the vinyl groups of protohemin IX with 
ethyl groups or hydrogen affects neither binding of the 
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prosthetic group to the apo-enzyme nor catalytic prop- 
erties of holo-PGHS; however, the bulkier substitutes 
(hydroxyethyl or acetyl groups) markedly decreased the 
holo-enzyme stability and catalytic activity. In addition 
protohemin IX with both carboxyl groups substituted 
lost the cofactor ability while the modification of one 
carboxyl did not influence the enzyme activity [12]. 
PGHS displays a phenomenon of fast and irreversible 
self-inactivation in the course of the reaction [14]. It has 
been suggested that two of at least seven intermediates 
in the process of the catalysis were responsible for the 
inactivation [14-171. The enzyme inactivation is accom- 
panied by hemoprotein radicals formation [18] and rel- 
atively slow destruction of the protein-heme complex 
WT. 
In this report we demonstrate the results of the chem- 
ical modification of histidine residues with DEPC in 
apo- and holo-PGHS and in holo-PGHS inactivated in 
the process of arachidonic acid conversion into prosta- 
glandin H2 and analysis of the content of the modified 
residues in 33 and 38 kDa fragments. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Arachidonic acid (AA), L-adrenaline and acetonitrile were products 
of Merck (Germany); hemine, L-histidine, diethyl pyrocarbonate 
(DEPC) were from Serva (USA), trypsin was from Worthington Bio- 
chemicals (USA), hydroxylamine from Fluka (Switzerland), p- 
APMSF from Calbiochem (USA). 
2.2. Preparation of PGHS patterns 
Homogenous apo-PGHS was obtained from ram seminal glands as 
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described previously [32,33]. Holo-PGHS was prepared by adding 100 
~1 200 PM hemine and 20 ~1 100 mM adrenalin to 1 ml 6 . 10m6 M
PGHS in Tris buffer pH 7.8 with 0.1% Tween 20 at 25°C. The enzyme 
was inactivated in the course of the reaction was holo-PGHS incu- 
bated with 1.5 . lo-’ M AA for 5 min at 25°C. 
2.3. Assay of enzyme activities 
Spectrophotometric assay of PGHS combined cycle-oxygenase plus 
peroxidase and peroxidase activities was done using saturating con- 
centrations of either AA or H202 with adrenalin as an electron donor. 
Both activities were detected at 480 nm (JASCO or Shimadzu) [8,12]. 
The enzyme concentration was 5-7 . lo-* M. The activities were esti- 
mated as initial velocities taken from the recorded kinetics at the first 
seconds after mixing. 
2.4. Modification with DEPC 
The enzyme solutions were adjusted to pH 6.0 and fresh prepared 
DEPC solution was added to each pattern (molar ratio 4O:l). UV 
differential spectra were recorded with a JASCO spectrophotometer 
at wavelengths 200-300 nm. The quantities of modified histidine resi- 
dues were calculated using an absorption coefficient 3,200 M-’ . cm-’ 
at 240 nm [20]. Aliquots were taken periodically and assayed for 
PGHS activities. 
2.5. Tryptic cleavage of PGHS 
All the three patterns of the enzyme and the respective modified 
forms were treated in Tris buffer pH 8.0 at 10°C with trypsin using 
1O:l molar ratio of 70 kDa subunit to trypsin. 20 ~1 aliquots were 
taken for electrophoretic assay and 150 ~1 aliquots for HPLC assay 
of the cleavage velocity. The reaction was stopped by adding p- 
APMSF (1:l). 
2.6. HPLC assay of the tryptic digests 
The assay was done as described previously [9] at Machery Nagel 
C4 Nucleosil 250 x 4 mm column using Beckman System Gold or 
Altex 420/100 chromatographs. The detection was performed at 280 
and 206 nm (Altex) or 230 nm (Beckman). For spectrophotometric 
assay peptide samples from several experiments were pooled. 
2.7. Spectrophotometric assay of mod$ed peptides 
UV spectra of 33 and 38 kDa fragments were recorded with a 
JASCO spectrophotometer at200-300 nm. 1 ml Tris buffer with 0.24 
mg of 33 kDa peptide or 0.34 mg of 38 kDa peptide from the native 
enzyme were used as a reference. The concentrations of modified 
peptides were adjusted to reference solution by dilution or concentra- 
tion. 
3. RESULTS AND DISCUSSION 
The purpose of this study was to investigate the regu- 
larities of DEPC interaction with holo-PGHS inac- 
tivated in the course of catalysis as compared with apo- 
and holo-PGHS. All three forms of the enzyme reacted 
with DEPC under conditions most specific for modifi- 
cation of histidine residues [20,21]. The most impressive 
changes in UV spectra of the reaction media at 240 nm 
occurred during the first 3-5 min and finished after 20 
min of incubation. As seen in Fig. 1 the maximal ab- 
sorptions corresponded to the modification of 4-5 his- 
tidine residues in holo-PGHS and 7-8 in apo-PGHS. In 
the case of holo-PGHS inactivated in the course of the 
reaction all the 18 histidine residues present in the en- 
zyme molecule became accessible for modification with 
DEPC. The concert and practically complete loss of the 
combined cyclooxygenase plus peroxidase and peroxi- 
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Fig. 1. Modification of PGHS by DEPC. PGHS (5.2-8.0 . 10e6 M) as 
holo- (curve l), apo- (curve 2) and holo-enzyme inactivated in the 
course of the reaction (curve 3) was incubated with DEPC (molar ratio 
1:40) at pH 6 and 25’C. The values on the ordinate represent he 
number of modified His residues per 1 mol of 70 kDa protein. 
dase activities was observed within 2 min for the enzyme 
modified to the apo-form (Fig. 2). The respective activ- 
Trypsin [22,23], proteinase K and chymotrypsin [23] 
ity changes in the holo-enzyme were not significant. The 
degree of modification during 2 min corresponded to 
the involvement of 5-6 histidine residues in apo-PGHS 
and l-2 in holo-PGHS. Treatment of the enzyme pat- 
terns with hydroxylamine at pH 7 was accompanied by 
the removal of some groups and the partial reduction 
of the enzyme activities (data not shown). 
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Fig. 2. Kinetics of histidine residue modification with DEPC (left 
ordinate) and PGHS inactivation (right ordinate). For reaction condi- 
tions see Fig. 1. Curve 1, apo-PGHS + DEPC; curve 2, holo- 
PGHS + DEPC; curve 3, combined cycle-oxygenase plus peroxidase 
activity corresponded to curve 1; curve 4, peroxidase activity corre- 
sponded to curve 1; curve 5, combined cyclooxygenase plus peroxidase 
activity corresponded to curve 2; curve 6, control of combined cyclo- 
oxygenase plus peroxidase activity of holo-PGHS. 
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Fig. 3. Kinetics of PGHS cleavage into fragments 33 and 38 kDa by 
trypsin. Curves 1, 3 and 5 correspond to modified patterns of holo- 
PGHS inactivated in the course of reaction, apo-PGHS and holo- 
PGHS respectively. Curves 2, 4 and 6 correspond to non-modified 
patterns 1, 3 and 5. 
have been reported to split apo-PGHS (70 kDa) into 
two fragments of 33 and 38 kDa. Under our experimen- 
tal conditions (see section 2), trypsin (Worthington Bio- 
chemicals) hydrolysed all three forms of PGHS and its 
modified forms (Fig. 3). The cleavage velocity of the 
enzyme inactivated in the course of the reaction was 
remarkably high as compared with apo- and holo-en- 
zyme. Our results demonstrate that the modification of 
the different enzyme patterns did not affect the velocity 
of their cleavage by trypsin. 
Spectrophotometric data on the 33 and 38 kDa frag- 
ments, assayed by the HPLC method for the modified 
histidine residues in them, are listed in Table I. The 
results obtained show that two of the three modified 
residues are located in the C-terminal fragment of the 
enzyme. 
Our experimental results and comparison of the most 
homologous regions for histidine of PGHS from vari- 
ous sources [13] with the known heme binding regions 
in oxidoreductases [24] allow us to suggest hat heme is 
most likely to shield the His-309 and His-388 residues. 
This supposition is in line with the data on site-directed 
replacement of histidine residues by alanine or glut- 
amine [7]. 
We have shown that all 18 histidine residues are ac- 
cessible to DEPC modification of the enzyme, inac- 
tivated in the course of the reaction, i.e. after 2-3 min 
incubation in the full reaction media. This suggests that 
the enzyme inactivation through reaction is accompa- 
nied by fast (comparable with time of inactivation) and 
impressive changes in the protein structure. 
From the data on abnormally high rates of trypsin 
hydrolysis of the enzyme inactivated in the course of 
reaction, and those on a faster hydrolysis of the homo- 
geneous PGHS samples with a low specific activity [25] 
it follows that the enzyme inactivation in vivo prepares 
PGHS for its rapid utilisation by proteolytic enzymes. 
Obviously, quick structural changes in the course of the 
reaction are a necessary link in the sequence of events 
regulating the level of highly physiologically active com- 
pounds in mammalian tissues and organs. 
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